Quarterly report pursuant to Section 13 or 15(d)

Schedule of Capitalized Technology (Details)

v3.22.2.2
Schedule of Capitalized Technology (Details) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2022
Dec. 31, 2021
Research and Development [Abstract]    
Balance, beginning of period $ 43,038 $ 25,867
Additional capitalized cost 17,085 49,970
Provision for amortization (15,593) (32,799)
Balance, end of period $ 44,530 $ 43,038